Company Profile

Diagnostic Photonics Inc (AKA: DxP)
Profile last edited on: 12/8/16      CAGE: 5C7V5      UEI: FNDNUZEMPST3

Business Identifier: Tissue microstructure medical imaging
Year Founded
2008
First Award
2012
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

200 South Wacker 31st Floor
Chicago, IL 60606
Location: Multiple
Congr. District: 07
County: Cook

Public Profile

Diagnostic Photonics, Inc. (DxP) Diagnostic Photonics is developing advanced imaging technology to assist physicians in the real-time evaluation of tissue microstructure. The company's breakthrough medical imaging technology originated in the Beckman Institute for Advanced Science and Technology at the University of Illinois, a leading interdisciplinary research institute. The firm's patented imaging technology generates diffraction-corrected images of tissue microstructure by solving the mathematical equations governing the physics of light at high speed, transforming defocused images into in-focus ones. Maxwell's equations describe the physics of light and enable this technology, called interferometric synthetic aperture microscopy. Optical imaging has proven its value in the field of ophthalmology where its widespread use in the imaging of the retina is a major clinical innovation. However, opthalmology systems are large tabletop instruments requiring precise placement of the patient and are poorly suited for many clinical applications. DxP's technological approach brings imaging to the point of care and places the power of optical imaging in the hand of the physician

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Andrew Citadine -- President & CEO

  Stephen Boppart -- Chief Medical Officer

  P Scott Carney -- Founder Chief Scientific Officer

  Anna Lisa Somera -- Director Of Quality, Regulatory Affairs, And Operations

  Adam Michael Zysk -- Director of Clinical Development

Company News

There are no news available.